首页> 外国专利> A pharmaceutical composition comprising a ribonuclease, deoxyribonuclease, betulin and glycyrrhizic acid or its salts: ammonium glycyrrhizinate, or radicals, or trisodium the treatment and prevention of influenza and other acute respiratory viral infections diseases

A pharmaceutical composition comprising a ribonuclease, deoxyribonuclease, betulin and glycyrrhizic acid or its salts: ammonium glycyrrhizinate, or radicals, or trisodium the treatment and prevention of influenza and other acute respiratory viral infections diseases

机译:药物组合物,其包含核糖核酸酶,脱氧核糖核酸酶,桦木素和甘草次酸或其盐:甘草次酸铵或自由基或三钠,用于治疗和预防流感和其他急性呼吸道病毒感染疾病

摘要

1. A pharmaceutical composition for the treatment and prevention of influenza and other diseases ARI containing enzymes: deoxyribonuclease and ribonuclease, betulin, glycyrrhizic acid or its salts: ammonium glycyrrhizinate, dipotassium or or trisodium as carriers: liposomes or beta-cyclodextrins, and acceptable excipients .2. A pharmaceutical composition according to claim 1 characterized in that it has the following composition, wt.%: 3. A pharmaceutical composition according to claim 1 characterized in that it has the following composition, wt.%:
机译:1.用于治疗和预防流感和其他疾病的ARI的药物组合物,其包含酶:脱氧核糖核酸酶和核糖核酸酶,桦木素,甘草次酸或其盐:甘草酸铵,二钾或三钠作为载体:脂质体或β-环糊精,以及可接受的赋形剂.2。 3.根据权利要求1的药物组合物,其特征在于它具有以下组成,重量%:3.根据权利要求1的药物组合物,其特征在于它具有以下组成,重量%:

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号